About H2-Pharma
H2-Pharma is a company based in Montgomery (United States) founded in 2013 was acquired by ANI Pharmaceuticals in February 2016. H2-Pharma offers products and services including Branded Pharmaceuticals, Generic Pharmaceuticals, and Non-Rx Products. H2-Pharma operates in a competitive market with competitors including AmerisourceBergen, Pfizer, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others.
- Headquarter Montgomery, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name H2-Pharma, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
ANI Pharmaceuticals
& 1 more
-
Employee Count
Employee Count
-
Acquired by
ANI Pharmaceuticals
(Feb 01, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of H2-Pharma
H2-Pharma offers a comprehensive portfolio of products and services, including Branded Pharmaceuticals, Generic Pharmaceuticals, and Non-Rx Products.
Sales and distribution of branded medications for various health needs.
Affordable alternatives for branded drugs in the pharmaceutical market.
Distribution of non-prescription health products to customers.
Funding Insights of H2-Pharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2020 | Amount | Seed - H2-Pharma | Valuation | Ardian |
|
Investors in H2-Pharma
H2-Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include ANI Pharmaceuticals and Ardian.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investment firm specializing in markets and partnerships.
|
Founded Year | Domain | Location | |
|
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
Founded Year | Domain | Location |
Investments & Acquisitions by H2-Pharma
Financial Statements - H2-Pharma
H2-Pharma Comparisons
Competitors of H2-Pharma
H2-Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Pfizer, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| domain | founded_year | HQ Location |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| domain | founded_year | HQ Location |
India's leading healthcare products distribution platform
|
|
| domain | founded_year | HQ Location |
Wholesaler & distributor of healthcare, medical, and pharmaceutical products
|
|
| domain | founded_year | HQ Location |
Diversified drugs are distributed by Renee in the United States.
|
Frequently Asked Questions about H2-Pharma
H2-Pharma was founded in 2013 and raised its 1st funding round 7 years after it was founded.
H2-Pharma is headquartered in Montgomery, United States. It is registered at Montgomery, Alabama, United States.
Brooke Cantey is the current CEO of H2-Pharma.
H2-Pharma was founded in 2013 and is headquartered in Montgomery, United States. Operations center on the distribution of generic pharmaceutical drugs within the healthcare sector. Supplies are provided to pharmacies, hospitals, and other providers across various markets. The company is led by Brooke Cantey, serving as CEO and President. Its online presence is maintained through the domain h2-pharma.com, supporting logistical and informational needs.
H2-Pharma's top competitors include Pfizer, Entero Healthcare and AmerisourceBergen.
H2-Pharma offers Branded Pharmaceuticals, Generic Pharmaceuticals, and Non-Rx Products.
H2-Pharma has 2 investors. Key investors include ANI Pharmaceuticals, and Ardian.